Virus-Like Particle & Nano-Particle Vaccines

29, 30 November – 1 December 2017, Biopolis, Singapore

  • Increase font size
  • Default font size
  • Decrease font size

Day One

Final Conference Programme | Wednesday 29th November 2017

08.45 Onwards
Arrival & Registration

09.45-10.00
Welcome & Opening Remarks
John Dangerfield (Anovasia Pte Ltd., Biopolis, Singapore)

SESSION 1:
OPENING PLENARY

Moderator: John Dangerfield (Anovasia Pte Ltd., Biopolis, Singapore)

10.00-10.45
‘VLPs for veterinary medicine: Transforming the success of human monoclonal antibodies into effective and affordable medicines for companion animals’
Martin Bachmann (Inselspital, Bern, Switzerland / University of Oxford, Oxford, UK)

10.45-11.30
‘Progress towards a norovirus vaccine’
Timo Vesikari (University of Tampere, Tampere, Finland)

11.30-12.15
‘Modern modular vaccines designed for rapid response’
Linda Lua1 and Anton Middelberg2 (1 The University of Queensland, Protein Expression Facility, St Lucia, Queensland, Australia; 2 The University of Adelaide, Faculty of Engineering, Computer and Mathematical Sciences, Adelaide, South Australia, Australia)

12.15-12.30
Questions

12.30-14.00
Lunch Break & Poster Set-Up

SESSION 2:
IMMUNE-MODULATION APPROACHES

Moderator: Linda Lua (The University of Queensland, St Lucia, Queensland, Australia)

14.00-14.30
‘Differentially designed chimeric virus-like particles for optimising immunisation outcomes’

Natalie J. Kingston1, Michiko Hyakumura1, Renae Walsh2, Carina Joe3, Liriye Kurtovic4, George Lovrecz3, Tim Adams3, James Beeson4, Stephen Locarnini2 and Hans J. Netter2 (1 Dept. of Microbiology, Monash University, Victoria, Australia; 2 Victorian Infectious Diseases Reference Laboratory, Melbourne Health, Victoria, Australia; 3 Commonwealth Scientific and Industrial Research Organisation (CSIRO), Clayton, Victoria, Australia; 4 Burnet Institute, Melbourne Victoria, Australia)

14.30-14.50
‘Understanding multiscale molecular/nano structures of engineered nano-adjuvants and their immuno-adjuvanticity’
Yannan Yang, Prasanna Lakshmi Abbaraju, Hao Song and Chengzhong Yu (Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Brisbane, Queensland, Australia)

14.50-15.10
‘Harnessing dendritic cells function to improved T cell responses in VLP-based vaccines’
Ariane C. Gomes1, Julius Muller1 and Martin F. Bachmann1,2 (1 Jenner Institute, University of Oxford, Oxford, UK; 2 Inselspital, Bern, Switzerland)

15.10-15.30
‘Engineering effective immune adjuvant by controlling shape, crystallinity and surface functionalization of aluminum oxyhydroxide nanoparticles’
Bingbing Sun (Dalian University of Technology, Liaoning, China)

15.30-16.00
Tea Break & Posters

SESSION 3:
DELIVERY TOOLS – I

Moderator: Hans Netter (Melbourne Health, Victoria, Australia)

16.00-16.30
‘Molecular painting as a tool to functionalise biomembrane surfaces’
John A. Dangerfield and Walter H Gunzburg (Anovasia Pte Ltd, Biopolis, Singapore and Institute of Virology, University of Veterinary Medicine, Vienna, Austria)

16.30-16.50
‘Synthetic virus-like particles prepared via protein corona formation enable effective vaccination in an avian model of coronavirus infection’
Chen-Yu Huang1,2, Shu-Yi Lin1, Zih-Syun Fang1,2, Chen-Hsuan Hsu1, Jung-Chen Lin2, Yuan-I Chen2, Bing-Yu Yao2, Che-Ming J. Hu2,3 and Hui-Wen Chen1,3 (1 Department of Veterinary Medicine, National Taiwan University, Taipei, Taiwan; 2 Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; 3 Research Center for Nanotechnology and Infectious Diseases, Taipei, Taiwan)

16.50-17.15
‘Development of protein capsular matrix vaccine technology: A nanoparticle delivery system’
Kevin P. Killeen (Matrivax Research & Development Corporation, Boston, Massachusetts, USA)

17.15-17.40
‘Norovirus VLP and rotavirus VP6 nanoparticles as a combination vaccine candidate’
Vesna Blazevic (Vaccine Research Center, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland)

 

VLPNPV 2017 Delegates

Login details will be supplied after you have registered for the event.


VLPNPV 2017 Sponsors

  • Mymetics
  • Matrivax
  • hVIVO
  • Anovasia
  • NatureGeneTherapy.com
  • John Innes Centre
  • APACI
  • VLP Biotech
  • Virometix
  • Fraunhofer USA
  • Vaccine Research Center
  • Alfa Wassermann
  • Sanofi Pasteur
  • Univac
  • Aldevron
  • Vironova
  • Medigen
  • Novavax
  • Medicago
  • VBI
  • Malvern

VLPNPV 2017 Downloads

VLPNPV 2017 Leaflet

VLPNPV 2017 Mailing List

Name
E-mail Address
What is 3+2-1?